Innovative Diagnostic Platform Entopsis offers cutting-edge diagnostic solutions such as OpsisDx, which enables cancer and disease detection through urine analysis, presenting a valuable opportunity to collaborate with healthcare providers, clinics, and laboratories looking for non-invasive, rapid diagnostic tools.

Expansion into Agriculture With the launch of PlantOpsis for plant testing, there is potential to partner with agricultural technology companies, crop science firms, and environmental monitoring organizations interested in innovative, nanotechnology-based testing methods.

Self-Diagnosis Technology Entopsis is developing a smartphone app integrated with a specialized glass slide for at-home disease testing, opening doors to consumer health markets, telemedicine services, and retail pharmacies seeking accessible, affordable diagnostic solutions.

Funding and Growth Potential Having secured $1 million in funding and generating revenues between $1 million and $10 million, Entopsis presents an opportunity for strategic investments and partnerships to accelerate product adoption and expand its market reach.

Disruptive Innovation Awards Recognized for its disruptive technology with awards like the 2016 Most Disruptive Technology Award, Entopsis' innovative platform positions it as a potential partner for large biotech and pharma companies seeking novel diagnostic tools and nanotechnology applications.